Brief: New Nordic Healthbrands Q4 EBITDA Down At SEK 5.7 Mln
Feb 26 (Reuters) - New Nordic Healthbrands AB NWND.ST :
* Q4 NET SALES AMOUNTED TO MSEK 117.8 (114.4), AN INCREASE
OF 3.0
PERCENT.
* Q4 GROSS MARGIN DECREASED TO 67.1 PERCENT (67.7)
* Q4 EBITDA DECREASED TO MSEK 5.7 (7.1).
Source text for Eikon: ID:nBQN61fBMQ
Further company coverage: NWND.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on New Nordic Healthbrands AB
See all newsBrief: New Nordic Healthbrands Reports Q2 EBIT Of SEK 9.0 Mln
Brief: New Nordic Healthbrands AB Q1 Group's Net Sales In Sek Decreased By 7.9% To Sek 132.5 Million
Brief: New Nordic Healthbrands Q4 Operating Profit Up At SEK 3.7 Mln
Brief: New Nordic Healthbrands Q3 Operating Profit SEK 2.7 Mln
Brief: New Nordic Healthbrands Q2 Net Sales Up At SEK 143.0 Mln